HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - IBI Group Holdings Limited (「IBI」或「公司」，及其附属公司统称为「集团」；股份代号：1547）为一家专注于投资在建筑环境相关业务的上市控股公司，今日公布截至二零二二年三月三十一日止财政年度（「二零二二财年」）之业绩。于回顾年内，集团的收益录得约405.9百万港元（二零二一财年：约556.7百万港元），毛利约为68.0百万港元（二零二一财年：79.4百万港元），公司拥有人应占溢利约为27.0百万港元，而上一财政年度约为54.4百万港元（当中包括集团策略投资分部的一次性溢利约43.6百万港元）。每股基本及摊薄盈利为3.4港仙（二零二一财年：6.8港仙）。集团保持强劲的财务状况，截至二零二二年三月三十一日止之现金及现金等价物达约为141.6百万港元（二零二一财年：87.1百万港元），并无银行借款。董事会建议派发截至二零二二年三月三十一日止年度之末期股息每股1.0港仙（二零二一财年：4.0港仙）。业务回顾1. 承建IBI在香港及澳门提供世界级的室内装修及楼宇翻新服务，涵盖两大类项目，分别为装修项目以及改建和加建项目。基于良好声誉及彪炳往绩，即使在Covid-19疫情的持续影响下，公司的香港部门于二零二二财年依旧忙碌，年内完成11个装修项目并获授14个项目。于回顾年内，集团录得来自承建分部的收益约403.9百万港元（二零二一财年：511.0百万港元），分部毛利激增91.0%至约67.4百万港元。2. Building solutions于二零二零年四月，IBI成立附属公司Building Solutions Limited（「BSL」），提供可提升建筑环境表现及福祉的产品及服务，以为用者提供现代、健康及高性能的空间。回顾年内，BSL一直努力发展业务及争取订单。于营运的第二年，其市场渗透率明显大幅上升，销售数据录得改善。新获得分销权的尖端照明产品广受好评，这将反映在下一个财政年度的销售数据之中。于二零二二财年，BSL录得分部亏损约2.7百万港元。3. 策略投资于本财政年度，集团部分剥离其早期股票投资，该等投资于上一个报告期间产生显著回报。此外，集团的房地产相关投资交易亦取得巨大的早期成功。于二零二二财年后期，集团于日本北海道取得紧邻规划中的新干线（高速铁路线）未来站台的建设用地，现正与当地发展专家合作，以确定如何有效利用该土地以及其发展时机。展望未来，集团将继续寻求潜在投资机会。于财务报告期后，集团收购位于爱尔兰都柏林市中心的大楼Adelaide Chambers。该投资是一座约20,000平方英尺商业办公空间的旧式建筑，极具升值潜力，待进行大楼升级及租赁改善等升级项目后，可望增加资产的整体价值，并为集团带来额外利润。展望未来香港现时已解除疫情期间实施的诸多限制，生活正迅速回归正常。集团相信，待严格的检疫限制进一步减少，市场环境逐步稳定下来，商业活动将恢复正常，届时香港将重拾其国际地位。展望未来，集团相信分配予投资的资本将于下一个财政年度悉数归属。IBI主席兼行政总裁Neil Howard先生表示：「尽管COVID-19大流行带来前所未有的挑战，但我们依然坚定地推动增长和投资策略。IBI对来年充满期盼，相信随着我们慢慢进入疫情后期，营商环境将不断改善。得益于策略业务决定，IBI继续表现稳定，在如此艰难的时刻能够留住全体员工，实在让我们感到十分自豪。此外，我们很高兴看到附属公司，尤其是BSL的增长，并期待公司从初创踏入发展阶段后，财务状况将显著录得改善。二零二二财年的业绩证明我们有能力提供综合创新解决方案，我们期待未来能为股东带来更强劲的业绩，创造更多长远价值。」关于IBI Group Holdings Limited（股份代号︰1547）IBI Group Holdings Limited 为香港主板上市控股公司，专注于建筑环境方面的投资。集团的主要投资领域包括建筑和装修承建、提供创新和节能照明及空气质量检测产品的企业，以及寻找房地产开发和其他建筑环境的投资机会。集团以提供多项专业及优质的产品、服务和客户体验为宗旨，为客户提供具有创新、可持续性、具环境敏感性和影响力的体验。有关IBI Group Holdings Limited的详情，请浏览网站：https://ibighl.com/. Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
MC and Maruha Nichiro Agree to Establish New Joint Venture in Salmon (land-based)
TOKYO, Jun 30, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Corporation (MC) and Maruha Nichiro Corporation (Maruha Nichiro) are pleased to announce our agreement to establish a new joint venture company, ATLAND Corporation (ATLAND), that will specialize in the land-based production of salmon. ATLAND will be established in Nyuzen town of Toyama prefecture in around October 2022.1 The investment ratio of ATLAND will be MC 51% and Maruha Nichiro 49%. Following the establishment of the company, a land-based aquaculture facility with a capacity of 2,500 tons (live weight equivalent) will be constructed in Nyuzen town, with the aims of starting operations in 2025 and completing the first delivery in 2027. MC and Maruha Nichiro have been discussing the joint promotion of this project since March 2021. This project is expected to help develop a sustainable and stable land-based production system, efficient digital-tech-based operations, local production for local consumption, and progress in decarbonization. Our companies are both dedicated to leveraging our strengths and businesses to simultaneously generate economic, environmental and societal value. Local Production for Local Consumption of SalmonThere are few suitable locations for conventional salmon aquaculture, due to the need for year-round low seawater temperatures, mild weather and wave activity. For those reasons, the vast majority of the world's farmed salmon is produced in Norway and Chile, but expectations are that global demand for this high-quality animal protein will continue to grow in the future. The aim of our joint project is to create a local-production-for-local-consumption business model in Japan's salmon industry. Low-Carbon, Carbon-Free / DigitalizationThis business model is expected to produce fewer greenhouse gas emissions compared to the practice of importing fresh salmon to Japan by air from salmon-farming countries.In addition, land-based aquaculture that uses Recirculating Aquaculture Systems (RAS)2 is highly compatible with digital technologies. These systems use advanced water-treatment technologies to control and manage the farming environment. By employing these methods, we aim to take advantage of AI and IoT to stabilize production, and otherwise optimize our own salmon farming operations. Water Resources in Nyuzen TownATLAND's facility uses ground water originating from the Kurobe River and deep seawater3 from the Toyama bay. Deep seawater is characterized by its cleanliness and low, stable temperature, which makes it possible to operate the facility by reducing the amount of energy required to create a water environment suitable for land-based production. 1. Completion of this project is subject to the approval of the relevant regulatory authorities.2. This model of land-based salmon aquaculture involves using special technologies to circulate water in and out of tanks where the fish are raised. The water is treated, removed of waste, and cleaned before it is pumped back into the tanks. This creates a controlled environment that supports health and welfare of the salmon throughout the growth cycle.3. In Toyama prefecture, a large amount of low-temperature "Japan Sea Proper Water" exists at depths of 300m or more. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
DOCOMO and CyberAgent to Establish New Advertising Company: Prism Partner Inc.
TOKYO, Jun 30, 2022 - (JCN Newswire via SEAPRWire.com) - NTT DOCOMO, INC. and CyberAgent, Inc. have announced that they have agreed to establish a new company, Prism Partner Inc., to utilize DOCOMO and CyberAgent's business resources for advertising.1. BackgroundIn 2021, online ad spending in Japan totaled nearly 2.71 trillion yen, up 21.4% from the previous year and the first time that online ad spending exceeded that in the four traditional media of television, radio, newspapers, and magazines.*1 Furthermore, Japan's market for digital sales promotions is forecast to grow to 250 billion yen by 2024. *2 In response, DOCOMO, with a membership base of over 89 million people, and CyberAgent, with a proven digital advertising track record in Japan, have decided to support advertisers by providing them with advertising products incorporating the two companies' knowledge and assets.2. New company's businessProvide solutions covering everything from digital promotions to CRMPrism Partner will sell DOCOMO's targeted ad products based on DOCOMO's service usage information and other member data as well as other online and offline data.*3 Prism Partner will support development and sell DOCOMO's digital promotions and advertising products that continuously use d POINTs to encourage purchases and perform purchase-effect analyses. Through the integration of CRM tools, such as DOCOMO's Super Sales Program*4 marketing platform and ad-delivery data, Prism Partner will go beyond simply serving customer ads by providing operational support for action that increases loyalty and trust for products and brands.Provide new targeted-ad avenues for developers of games and other appsFor app developers who utilize DOCOMO membership information and app-usage data*5, Prism Partner will support development and sales of DOCOMO's advertising products. DOCOMO data will be integrated with Dynalyst, CyberAgent's dynamic retargeting ads designed specifically for smartphone apps,*6 enabling customers to benefit from advanced ad technology and customization.3. Each company's rolesDOCOMODeliver targeted ads effectively by using purchase behavior data based on d POINTs and d-BaraiTM usage histories from some 89 million d POINTs members and other media touchpoints (used anonymously and within the scope of the Privacy Policy) to estimate customers' online and offline interests.Contribute to manufacturers' and retailers' sales promotions by revitalizing the d POINTs and d-Barai ecosystem and encourage customer purchases.Help advertisers expand their marketing activities by analyzing ad targets and customer preferences with AI,*7 using location information obtained with customer consent,*8 DOCOMO data on how services are being used by customers, and d POINTs and d-Barai purchase information.CyberAgentLeverage Japan's top-level digital-advertising sales, operational and advertising development capabilities to provide advertisers with comprehensive assistance, from ad-serving system development to ad-operating system construction and sales.Apply knowledge from developing Japan's top-class DSP and from the AI Lab, an AI R&D organization involved in digital marketing, to develop ad-serving systems for maximized and measurable ad impact.Leverage partnerships with retailers by supporting digital transformation to formulate sales-promotion plans and measure sales-promotion impact, both online and offline.4. OutlookDOCOMO and CyberAgent, working through their new company Prism Partner, will develop advertising products and drive sales to advertisers while also utilizing DOCOMO's proprietary data, points, media, and other marketing assets, as well as CyberAgent's AI and digital marketing knowledge, ultimately to identify and maximize the impact of advertisements integrated both online and offline.(1) Source: Dentsu Inc. research report (in Japanese): "2021 Ad Spending in Japan"www.dentsu.co.jp/news/release/2022/0224-010496.html(2) Source: CyberAgent, Inc. research report (in Japanese):"Execution of Market Size Research on Digital Advertising to Draw Customers to Stores (O2O Ads)" www.cyberagent.co.jp/news/detail/id=23249(3)(5)(7)(8) Conducted within the scope of the DOCOMO Privacy Policy and d Menu "Site Terms of Use"DOCOMO Privacy Policy (in Japanese): www.nttdocomo.co.jp/utility/privacy/Site Terms of Use (in Japanese): https://smt.docomo.ne.jp/portal/src/terms_ad3.htmlWith the Personal Data Dashboard, customers can always select to a certain extent to accept or reject DOCOMO's use of location information and usage information, such as the user's IP address. For more about the Personal Data Dashboard: https://datadashboard.front.smt.docomo.ne.jp/For more about DOCOMO Ads (digital ads) provided by DOCOMO: https://smt.docomo.ne.jp/portal/ad/about/docomoad.html (in Japanese)Super Sales Program, which sends messages and information on deals from accepting (4) merchants to customers through the d POINTs and d-Barai apps when d POINTs or d-Barai are used at stores, is a marketing platform for effective sales promotions: https://ssw.web.docomo.ne.jp/marketing/super_sales_program/ (in Japanese)(6) Dynamic retargeting ads automatically generate banner ads that display information tailored to each customer's tendencies and interests. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
IBI Group Announces FY2022 Annual Results, Steadfast Resilience Albeit Market Challenges
HONG KONG, Jun 30, 2022 - (ACN Newswire via SEAPRWire.com) - IBI Group Holdings Limited ("IBI" or the "Company", together with its subsidiaries as the "Group"; Stock Code: 1547), a publicly listed company that holds investments in companies focusing on the Built Environment, today announced its business results for the financial year ended 31 March 2022 ("FY2022").During the year under review, the Group recorded an income of approximately HK$405.9 million (FY2021: HK$556.7 million). Gross profit was approximately HK$68.0 million (FY2021: HK$79.4 million) and profit attributable to the owners of the Company was approximately HK$27.0 million compared with approximately HK$54.4 million from the previous financial year (which included a one-off gain of approximately HK$43.6 million generated from its strategic investments segment). Basic and diluted earnings per share was HK3.4 cents (FY2021: HK6.8 cents).The Group maintained a strong financial position with cash and cash equivalents of approximately HK$141.6 million (FY2021: HK$87.1 million) and no bank borrowings as at 31 March 2022. The Board has recommended payment of a final dividend of HK1.0 cent per share for the year ended 31 March 2022 (FY2021: HK4.0 cents).Business Review1. ContractingIBI provides world-class interior fitting out and building refurbishment services in Hong Kong and Macau, undertaking two main types of projects namely fitting-out projects and alteration and addition projects. Owing to its established reputation and proven track record, the Hong Kong component of the Company remained busy during FY2022 despite the continuing shadow cast by the Covid-19 pandemic, completing 11 fitting-out projects and being awarded 14 more. During the year under review, revenue from the segment totaled approximately HK$403.9 million (FY2021: HK$511.0 million) with segmental gross profit increasing by an exceptional 91.0% amounting to approximately HK$67.4 million. 2. Building SolutionsIn April 2020, IBI set up its subsidiary, Building Solutions Limited ("BSL"), a provider of products and services that enhance the performance and well-being of the built environment in order to provide modern, healthy and high-performing spaces for its occupants. During the year under review, BSL has been working diligently to develop the business and secure orders. The second year of its operations has shown significant penetration into the market, leading to improved sales figures. BSL has additionally secured distribution rights to a cutting-edge lighting product that has been very well received and will be reflected in the sales figures for the coming financial year. BSL registered a segment loss of approximately HK$2.7 million in FY2022.3. Strategic InvestmentsThe financial year was spent in part, divesting the Group of its earlier stock investments which had generated phenomenal returns in the previous reporting period. In addition, IBI's efforts were targeted toward property-related investment deals and these efforts have generated considerable early success. During the latter part of FY2022, the Group secured development land in Hokkaido, Japan located in close proximity to a future station of the planned Shinkansen high-speed rail line, and is now working with a local development specialist to establish the most efficient use of the land and the timing of the development. Moving forward, the Group will continue to look at potential investment opportunities. Subsequent to the financial reporting period, the Group recently acquired Adelaide Chambers, a building located in the heart of Dublin, Ireland. The investment is a period building with approximately 20,000 square feet of commercial office space and is a value-add proposition with improvements to be made, in both building upgrades and lease improvements, in order to increase the overall asset value and to secure additional profits for the Group.ProspectsHong Kong has now lifted many of the restrictions put in place during the pandemic and life is very quickly returning to normal. The Group is optimistic that Hong Kong will start to regain its full international status once the city's strict quarantine restrictions are further reduced, returning to more normal business activity levels along with stabilization of the market environment. Moving forward, the Group is confident that the capital allocated for its investment will be fully vested within the coming financial year.Mr. Neil Howard, Chairman and CEO of IBI, said, "Amid unprecedented challenges created by COVID-19 pandemic, we have remained steadfast and resilient in driving our growth and investment strategies. IBI is excited for the year ahead and believes that the business environment will move from strength to strength as we slowly transition into the pre-pandemic period. As a result of our strategic business decisions, IBI continued to deliver stable performance and we are extremely proud to be able to retain our full workforce during these challenging times. We are thrilled to see growth in our subsidiaries, especially BSL, and look forward to reporting significantly improved financials as it moves out of its infancy and into its development phase. Our FY2022 results are a testament to our ability to provide integrated, innovative solutions and we look forward to bringing stronger results and add long-term value to shareholders."About IBI Group Holdings Limited (stock code: 1547)IBI Group Holdings Limited is a publicly listed holding company on the Hong Kong Stock Exchange, focused on investments in the Built Environment. The Group's investments whilst principally centering around the role of contracting, including businesses providing an innovative, high-quality product and supply solutions across a diverse range of the built environment. Our mission is to deliver premium products, services and customer experiences with a strong influence on innovation, sustainability and wellness. For more information, please refer to IBI's website: https://ibighl.com/. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
Galaxy Survivor, a new 3D NFT Game, aims to foster the next blockchain gaming generation
Hanoi, Vietnam, June 30, 2022 – (SEAPRWire) – Virtual Game Studio, one of the renowned game studios in the billion-dollar industry, has introduced a highly anticipated NFT game, Galaxy Survivor. Galaxy Survivor is a real-time strategy game that combines the competitive play-to-earn [P2E] model, well-thought-out role-playing, and NFT gaming technology. Leveraging blockchain technology, Galaxy Survivor allows gamers to enjoy an immersive, truly satisfying, and competitive game while completing missions, joining battles, and after that, receiving colossal and tradeable rewards. Galaxy Survivor aims to introduce a stable NFT gaming economy. Many NFT games are unsustainable and shallow – excess supply of tokens, unrealistic mint ratios, and the current fad of pumping and dumping tokens. Galaxy Survivor hopes to solve these sticking points and NFT devaluation by creating a brand-new NFT system called NFTism Balancing system includes NFT Recycle System, Rental Mechanism and NFT Quantity Limit System with DAO voting. Galaxy Survivor NFT Game Integrating a unique theme bordering galaxies and warships, all Galaxy Survivor NFTs are designed by strong in-house team from sketch to finish. The team’s decision to undertake this task aligns with Galaxy Survivor’s greater goal to showcase creativity and enthusiasm. One standout feature of the Galaxy Survivor NFT is the well-crafted, smooth 3D designs that deliver an unreal viewing experience for players. Galaxy Survivor employs different cinematic angles, giving players an unprecedented visual experience. Augmented Reality [AR] technology enhances the game visuals, allowing players to interact with game characters and artifacts, indirectly increasing NFT value. To curb the ongoing devaluation of NFTs, Galaxy Survivor presents NFT rental, voting, and recycling mechanisms. Galaxy Survivor NFT Types Galaxy Survivor integrates a divergent NFT system. There are 78 unique models of warships and over 300 models of wargears and gems. These idiosyncratic ranges of NFTs enable players to equip warships seamlessly. The varying NFTs in the Galaxy Survivor universe are – NFT Blueprints, NFT Warships, NFT Wargear, and NFT Legacy Gems. The NFT Warships are specifically for building the strongest team. This NFT type will have five unique rarity levels; Normal, Rare, Super-rare (SR), Super SR, and Ultra rare. NFT Blueprints will comprise a mysterious box containing a variety of NFT Warships that players can either buy or win by participating in several events. NFT Wargears are tiny parts of warships. Each will have individual stats and skill sets capable of boosting the power of the warships. The Wargear NFT type has three levels of uniqueness – Iron, Silver, and Gold. The NFT Legacy Gems, on the other hand, will have a direct attachment to warships. Gamers can utilize Legacy Gems to equip and strengthen their warships, dispelling the need to buy a new Warship NFT. The distinctive nature of the Galaxy Survivor NFT allows gamers to customize NFT holdings conveniently. By personalizing the Warship NFTs, these tokens will have more real value besides the obvious one – in-game character. Galaxy Survivor Solutions to prevent NFT devaluation As part of its long-term plans to address NFT devaluation, Galaxy Survivor incorporates an NFT recycling system, voting mechanism, NFT quantity limit, and a rental mechanism. In the Galaxy Survivor Universe, all NFTs such as Warships, Wargears and Legacy Gem will have a fixed-durability stat which will be burn down when being used. Along with that, each NFT also has a maximum number of times to be repaired (Warships, Wargears) or recharged (Legacy Gems). When those resources are used up, NFTs will be converted into “Broken NFTs” which only have collectible value and can no longer be used in the Game, except in NFT Recycle System. The NFT recycling system is where players can combine broken NFTs into a new NFT with a higher rarity and strength than the old NFT. This Gacha mechanism will attract many players to buy broken NFTs to try their luck and the marketplace will become more vibrant and create liquidity for broken NFTs. Galaxy Survivor aims to build a thrilling gaming universe where players can enjoy genuinely satisfying gameplay in a balanced game economy. To improve the game quality and the experience of gamers, the team constantly releases new versions and attracts thousands of registered accounts. Players can play the game HERE. That’s not all: Galaxy Survivor has launched strategic marketing campaigns that will keep gamers engaged with the project as well as share more about their diverse NFT system and innovative methods that make them one of the leading projects for the new generation of blockchain games. To fully experience the features and the well-designed NFT items, Galaxy Survivor will soon announce INO rounds in which the community can purchase their favorite NFTs for a strong formation when taking part in the battles. If you want to sign up for early participation, go to Galaxy Survivor Marketplace and purchase Ticket Sale to reserve whitelist slots and get discounts for the INO rounds with many other rewards: Special NFT items valued $2000, various kinds of NFT and in-game items, Oculus VR Headset, stable coins, and so on. About Galaxy Survivor Galaxy Survivor is the brainchild of Virtual Game Studio. It was designed to provide a fantastic gaming experience where players can enjoy exciting, strategic P2E-based, competitive battles and embark on adventurous missions. Employing advanced technology, Galaxy Survivor introduces a new concept capable of abating NFT devaluation in the P2E gaming industry. Social Links Twitter: https://twitter.com/galaxy_survivor Telegram: https://t.me/galaxysurvivor Discord: https://discord.com/invite/7UsmnVDE3d Facebook: https://www.facebook.com/GalaxySurvivor Medium: https://medium.com/@GalaxySurvivor Youtube: https://www.youtube.com/channel/UCOzf2JolnIcLX6EP_gBlLDQ Media Contact Brand: Galaxy Survivor Contact: Giang, CEO Email: admin@galaxysurvivor.io Website: https://www.galaxysurvivor.io/ SOURCE: Galaxy Survivor The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
MHIENG’s First Compact CO2 Capture System Goes into Commercial Operation at Biomass Power Plant in Hiroshima
TOKYO, Jun 30, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Heavy Industries Engineering, Ltd. (MHIENG), a part of Mitsubishi Heavy Industries (MHI) Group, has launched full-scale operation, on schedule, of a compact CO2 capture system ordered in November 2021 by Taihei Dengyo Kaisha, Ltd. It is the first system of its kind to go into commercial operation.Seifu Shinto biomass power plant (photo courtesy of Taihei Dengyo Kaisha, Ltd.)The compact CO2 capture system was installed at a 7-megawatt (MW) class biomass power plant operated by Taihei Dengyo in Seifu Shinto, a suburb of Hiroshima City. The system has the capacity to capture 0.3 metric tons per day (tpd) and is based on a highly versatile standardized design requiring an installation space of just five meters in length and two meters wide. Its modular configuration enabled rapid transportation to the site and easy installation.The CO2 captured from the plant's flue gas will be used for growing vegetables in on-site greenhouses - an example of the circular economy. By fully consuming all captured CO2 at its carbon-negative power plant, Taihei Dengyo looks to help prevent global warming and promote a decarbonized society. The biomass power plant where the system was installed was delivered by Mitsubishi Heavy Industries Power IDS, Ltd. in October 2019.As the next step, MHIENG will perform demonstration test of operational support services for the plant using a proprietary remote monitoring system with the customer. MHIENG ultimately aims to put in place a fully integrated customer support package, encompassing everything from system design and delivery to after-sale servicing, operation and maintenance. MHIENG also has plans to expand its lineup of compact CO2 capture systems as well as to pursue reduced installation, operation and maintenance costs and faster deliveries. This will allow it to offer diverse solutions to the customer's needs especially of relatively small-scale industrial and other facilities.MHI Group is currently strengthening its position in the Energy Transition, and the development of a CO2 solutions ecosystem is a core component of that initiative. Carbon dioxide capture, utilization and storage (CCUS) is garnering attention as an effective means for realizing a carbon neutral society.MHIENG, as a leading company in decarbonization and key to the group's strategy regarding Energy Transition, will continue to help achieve wide-scale greenhouse gas emission reduction by introducing its high-performance CO2 capture technology globally. It will also press ahead in developing new solutions to contribute to global environment protection.About MHIENG's CO2 capture technologiesSince 1990, MHIENG (originally MHI) has undertaken the development of the KM CDR Process (Kansai Mitsubishi Carbon Dioxide Recovery Process) and Advanced KM CDR Process together with The Kansai Electric Power Co., Inc. (KEPCO). As of June 2022, MHIENG has delivered 14 commercial plants adopting the KM CDR Process, and two more plants are currently under construction. This robust track record makes MHIENG a global leader in CO2 capture technologies.For further information on MHIENG's CO2 capture plants: www.mhi.com/products/engineering/co2plants.htmlAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
Mazda Production and Sales Results for May 2022
HIROSHIMA, Japan, Jun 30, 2022 - (JCN Newswire via SEAPRWire.com) - Mazda Motor Corporation's production and sales results for May 2022 are summarized below.I. Production1. Domestic ProductionMazda's domestic production volume in May 2022 decreased 30.2% year on year due to decreased production of passenger vehicles.[Domestic production of key models in May 2022]CX-5: 16,879 units (down 15.9% year on year)CX-30: 4,893 units (up 42.1%)CX-9: 2,733 units (down 34.7%)2. Overseas ProductionMazda's overseas production volume in May 2022 decreased 10.6% year on year due to decreased production of passenger vehicles.[Overseas production of key models in May 2022]MAZDA3: 7,720 units (down 5.0% year on year)CX-30: 7,658 units (down 7.3%)MAZDA2: 3,698 units (down 28.6%)II. Domestic SalesMazda's domestic sales volume in May 2022 decreased 36.7% year on year due to decreased sales of passenger and commercial vehicles.Mazda's registered vehicle market share was 2.1% (down 1.3 points year on year), with a 2.3% share of the micro-mini segment (up 0.4 points) and a 2.2% total market share (down 0.6 points).[Domestic sales of key models in May 2022]MAZDA2: 848 units (down 36.9% year on year)CX-5: 813 units (down 2.0%)MAZDA3: 341 units (down 64.6%)III. ExportsMazda's export volume in May 2022 decreased 52.7% year on year due to decreased shipment to North America, Europe, Oceania and other regions.[Exports of key models in May 2022]CX-5: 11,274 units (down 46.2% year on year)CX-30: 2,350 units (down 38.7%)CX-9: 1,992 units (down 53.8%)IV. Global SalesMazda's global sales volume in May 2022 decreased 41.9% year on year due to decreased sales mainly in the U.S., China, Europe and other regions.[Global sales of key models in May 2022]CX-5: 21,392 units (down 45.3% year on year)CX-30: 12,379 units (down 41.6%)MAZDA3: 11,353 units (down 43.3%) Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
JLMAG Awards the First SGS PAS 2060 Carbon Neutrality Declaration Certificate in the Global Rare Earth Permanent Magnet Industry
HONG KONG, Jun 30, 2022 - (ACN Newswire via SEAPRWire.com) - JL MAG Rare-Earth Co., Ltd. ("JL MAG" or the "Company", together with its subsidiaries, the "Group", SZSE: 300748; HKEX: 6680), a leading producer of high-performance rare earth permanent magnets ("REPMs") in China, is pleased to announce that the Company has been awarded the first SGS PAS 2060 carbon neutrality declaration certificate ("Certificate") in the global rare earth permanent magnet industry by SGS, an internationally recognized testing, inspection and certification institution. Both parties held a Certificate presentation ceremony at Ganzhou Jinjiang International Hotel on 30 June 2022. Mr. Chen Shuilian, Deputy Mayor of the People's Government of Ganzhou City of Jiangxi Province, Ms. Zhang Qiumei, Director of SGS Knowledge and Management Services in Southern District & Central and Western District, and Mr. Cai Baogui, Chairman and General Manager of JL MAG jointly attended the ceremony. Mr. Cai Baogui, Chairman and General Manager of JL MAG delivered a welcome speech.Ms. Zhang Qiumei, Director of SGS Knowledge and Management Services in Southern District & Central and Western District presented the Certificate to Mr. Cai Baogui, Chairman and General Manager of JL MAG.PAS 2060 is the internationally recognized carbon neutrality standard, which requires enterprises to strive to reduce carbon emissions and achieve low-carbon production on the basis of quantifying greenhouse gas emissions. With regard to carbon emissions that cannot be reduced, PAS 2060 encourages enterprises to adopt voluntarily compensation and offset to achieve carbon neutrality. The PAS 2060 carbon neutrality declaration certificate proved that JL MAG's efforts in carbon neutrality have been highly recognized by the international authorities. The Company has established and implemented systematic management and identification of carbon emission sources in accordance with ISO 14064 standard. It also demonstrated to the SGS professional audit team that the Company has fulfilled the commitments and requirements of products and services within the scope of certification, with the system capable of meeting the organizational objectives. Meanwhile, on top of implementing the emission reduction plan, JL MAG has been committed to completely offsetting the remaining carbon emissions by taking relevant effective measures.JL MAG has been adhering to the philosophy of green development and fulfilling corporate responsibilities since its establishment. The Company facilitates the pursuit of carbon neutrality in China and around the world by providing rare earth permanent magnets to its top player customers. In 2021, the Company's sales volume of magnetic steel products for NEV drive motors was sufficient to equip approximately 1.24 million passengers NEVs 2021, facilitating to reduce of carbon emissions by approximately 2.56 million tonnes/year. The Company's sales volume of magnetic steel products for energy-saving VFACs was sufficient to equip approximately 48.50 million air conditioner compressors in 2021, facilitating the reduction of carbon emissions by approximately 17.55 million tonnes/year. The Company's sales volume of magnetic steel products for the wind power sector was sufficient to equip wind turbine generators with an approximate aggregate installed capacity of 8.65GW in 2021, facilitating to the reduction of carbon emissions by approximately 14.33 million tonnes/year. Combining the three key downstream areas, JL MAG facilitated the reduction of carbon emissions by approximately 34.44 million tonnes in 2021.In addition, JL MAG reduces its own carbon emissions through various energy conservation approaches, including technological innovation, lean production, management-driven energy conservation, technology-driven energy conservation, efficiency improvement, equipment upgrading, and conversion of green power. The Company also joined hands with Goldwind (002202.SZ; 02208.HK) to develop a green power program. The Company has also announced that it has entered into a strategic cooperation framework agreement with China Resources Power Investment Co., Ltd. Northern Branch, a management company established by China Resources Power (836.HK) in the northern region. Both parties will cooperate on a number of projects on the basis of the development and construction of new energy projects, including indemnificatory grid-connected centralized new energy projects, renewable energy replacement projects in industrial parks, thermal power flexibility retrofits supporting new energy projects, distributed wind power projects and permanent magnet motor transformation projects, to promote the Company's low-carbon production with green power. Looking forward, the Company has established a clear carbon reduction target, aiming to reduce its emission/consumption per unit by an average of 5% to 10% on an annual basis in the future through the increasing use of green energy and recycling of raw materials. Guided by the vision of "growing into the leading enterprise in the world rare earth permanent magnet industry", the Company will continue to enhance its product innovation and research and development, further improve energy efficiency, proactively develop and introduce photovoltaic power, and strive to achieve carbon emission reduction and carbon neutrality at the Group level and product level. JL MAG will realize its corporate mission of "Better Life with Rare Earth" with concrete actions and facilitate the pursuit of carbon neutrality in China and around the world.About JL MAG Rare-Earth Co., Ltd.JL MAG Rare-Earth Co., Ltd. ("JL MAG" or the "Company", together with its subsidiaries, the "Group", HKEX: 6680; SZSE: 300748) is a global leading producer of high-performance REPMS with rapid growth in the fields of new energy, energy conservation and environmental protection. The Company ranked first in the world by production volume of high-performance REPMs and by production volume of high-performance REPMs based on GBD technology in 2020. The Company's products are widely applied in downstream sectors including NEVs and automotive parts, energy-saving VFACs, wind power, 3C, industrial energy-saving motors, energy-saving elevators and rail transit. The Company has also established long-term and stable cooperative relationships with domestic and foreign top-tier companies in various sectors. The Company successfully listed its H shares on the Main Board of the Stock Exchange of Hong Kong Limited on January 14, 2022, making JL MAG the first high-performance REPM producer with dual listings of A-shares and H-shares in the world. Meanwhile, JL MAG successfully raised HK$4.241 billion. About SGSSGS is an internationally recognized testing, inspection and certification institution with more than 93,000 employees across over 2,600 branches and laboratories worldwide, building a global service network. SGS has been on the list of Forbes Global 2000, named as an industry leader by the Dow Jones Sustainability Index for the sixth year and included in the FTSE4Good Index for the third year. SGS-CSTC Standards Technical Services Co. Ltd. was founded in 1991 as a joint venture between SGS Group and China Standard Science and Technology Group. With an extensive network of 90 branches and more than 200 laboratories, it recruited more than 15,000 professionals to provide quality services. In China, SGS' service covers an array of industries such as textiles & garments, toys & children's products, houseware & sundries, electrical & electronics, agriculture & food, life sciences, cosmetics, personal care & household, petrochemicals, minerals, environment, industrial, transportation and e-commerce. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
金力永磁荣获稀土永磁行业全球首张SGS PAS 2060碳中和达成宣告核证证书
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 2022年6月30日中国领先的高性能稀土永磁材料生产商江西金力永磁科技股份有限公司（「金力永磁」或「公司」，连同其附属公司，统称「集团」；深交所股票代码︰300748/港交所股票代号：6680 ）欣然宣布，公司荣获稀土永磁行业全球首张由国际公认的测试、检验和认证机构SGS颁发的PAS 2060碳中和达成宣告核证证书。（「证书」）。双方于今日在赣州锦江国际酒店举行证书发布会，江西省赣州市人民政府副市长陈水连先生、SGS知识与管理服务事业群南区和中西区总监张秋妹女士、金力永磁董事长兼总经理蔡报贵先生等共同出席颁证仪式。金力永磁董事长兼总经理蔡报贵先生致欢迎辞。金力永磁董事长兼总经理蔡报贵先生及SGS知识与管理服务事业群南区和中西区总监 张秋妹女士进行颁证仪式。PAS 2060是国际公认的碳中和标准，要求企业在量化温室气体排放的基础上努力节排，实现低碳生产模式。就无法减省的碳排放量，PAS 2060亦鼓励企业自愿采取补偿和抵消方式实现碳中和。此次金力永磁荣获PAS 2060碳中和达成宣告核证证书，足证公司在「碳中和」方面所作出的努力已获国际权威机构的高度认可。公司已根据ISO 14064标准建立和实施对碳排放源的系统管理和盘查，并向SGS专业的审核团队展示出公司已达成认证范围内产品和服务所承诺的要求，以及具备组织方针目标的系统能力。同时，金力永磁亦承诺在实施减排方案的基础上，通过采取相关有效方式全部抵消剩余的碳排放。自成立以来，金力永磁一直致力践行绿色发展的理念，积极履行企业责任。公司通过向多家龙头企业提供稀土永磁材料，共同助力中国及世界各地实现碳中和目标。于2021年，公司新能源汽车驱动电机磁钢产品销售量可装配新能源乘用车约124万辆，每年助力减少碳排放量约256万吨；节能变频空调磁钢产品销售量可装配空调压缩机约4,850万台，每年助力减少碳排放量约1,755万吨；风电磁钢产品销售量可装配风力发电机的装机容量约8.65GW，每年助力减少碳排放量约 1,433万吨。综合上述三大关键下游领域，2021年金力永磁实现助力碳减排合共约3,444万吨。此外，金力永磁亦通过技术创新、精益生产、管理节能、工艺节能、效率提升、设备更新换代、转换绿色电力等各种节能方式减少自身碳排放。公司已与金风科技（002202.SZ; 02208.HK）合作开展绿色电力计划。公司亦公布了与华润电力（836.HK）设立在北方地区的管理公司华润电力投资有限公司北方分公司签订《战略合作框架协议》，以新能源项目开发建设为基础，于多个项目展开合作，包括保障性并网集中式新能源项目、工业园区可再生能源替代项目、火电灵活性改造配套新能源项目、分布式风电项目和永磁电机改造项目，继续以绿色电力推动了公司的低碳生产。展望未来，金力永磁已制定明确的减排目标，将通过增加绿色能源的使用并加强对原材料的回收利用，未来预计实现每年平均减少5%至10%的单位排放或能耗。在「成为世界稀土永磁行业领军企业」愿景的引领下，公司将继续加大产品创新及研发，进一步改善能源效率，大力开发和导入光伏电力，持续实现集团层面和产品层面的碳减排与碳中和，以切实行动真正实现「用稀土创造美好生活」的企业使命，助力中国及世界各地迈向碳中和。关于江西金力永磁科技股份有限公司江西金力永磁科技股份有限公司(「金力永磁」或「公司」；港交所股票代号：6680 / 深交所股票代号︰300748) 为新能源和节能环保领域中增长迅速的全球领先高性能稀土永磁材料生产商。2020年按高性能稀土永磁材料产量计及按使用晶界渗透技术生产高性能稀土永磁材料计，公司均位列世界第一。公司产品被广泛应用于新能源汽车及汽车零部件、节能变频空调、风力发电、3C、工业节能电机、节能电梯、轨道交通等领域，并与各领域国内外龙头企业建立了长期稳定的合作关系。于2022年1月14日，公司在香港联交所成功发行H股，成为首家全球高性能稀土永磁材料行业「A+H」上市公司，同时成功募集42.41亿港元。关于SGSSGS 是国际公认的测试、检验、认证机构，在全球拥有超过93,000名员工，分布在2,600多个分支机构和实验室，具有全球性的服务网络。SGS长期位列福布斯全球2000强，并连续六年入选道琼斯可持续发展指数及第三年入选富时社会责任指数。SGS通标标准技术服务有限公司由SGS集团和隶属于国家市场监督管理总局系统的中国标准科技集团共同于1991年成立，现已在全国建成了90多个分支机构和200多间实验室，拥有15,000多名训练有素的专业人员。在中国，SGS的服务能力已全面覆盖到纺织品及鞋类、玩具及婴幼儿用品、家居及轻工产品 、电子电气、农产食品、生命科学、化妆品及个人护理、石油化工、矿产、环境、工业、交通和电子商务等多个行业的供应链上下游。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
天齐锂业启动招股：全球最大的锂开采运营商 客户群稳定庞大
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 据彭博终端机报道，近年来，随着全球新能源汽车市场的迅速增长及储能产业的飞速发展，金属锂的市场需求趋于旺盛。6月30日，中国及全球领先的锂业龙头——天齐锂业开启港股招股，最高发售价为每股港82元，公司的上市进程更进一步。公开数据显示，天齐锂业是中国及全球领先的锂生产商，于2010年8月31日在深圳证券交易所上市（股份代号：002466）。公司通过子公司泰利森，持有格林布什矿场的锂矿开采权，运营涵盖锂价值链的关键环节，包括开采锂矿石并生产锂精矿及生产锂化合物及衍生物。持续加码在全球的业务布局 市场份额及市场地位不俗根据伍德麦肯兹报告（下同），天齐锂业是中国唯一通过大型、一致且稳定的锂精矿供给实现100%自给自足以及全面垂直整合锂矿的锂生产商。按2021年的锂精矿产量计，公司的一家子公司为全球最大的锂开采运营商，市场份额为38%，且按2021年锂产生的收入计，公司排名第三。按2021年的产量计，公司亦为全球第四大及亚洲第二大锂化合物生产商，市场份额分别为7%及12%。众所周知，锂电池是电动汽车的重要组成部分，天齐锂业具备丰富的产品组合，结合先进的生产能力，能够制造出锂化合物及衍生物，以满足主要电池材料制造商的严格要求。公司的碳酸锂产品被认为是中国市场的标杆产品，是2021年世界第二大电池级碳酸锂供货商及世界前十大电池级氢氧化锂供货商之一。为进一步扩大产能，天齐锂业持续加码在全球业务布局。公司在西澳洲奎纳纳建造了一个电池级氢氧化锂制造厂，一期工厂年产能为24,000吨，施工已完成且目前正处于试生产阶段。同时，公司正就奎纳纳电池级氢氧化锂二期工厂的建设计划进行可行性研究及编制所需资本开支估算，并且在四川省遂宁市建设碳酸锂工厂，而建成投产后预计年产能分别可再增加24,000吨和20,000吨。凭借在优质锂原料自给自足的能力、多样化的产品组合以及领先的生产能力，天齐锂业能够满足电动汽车和储能领域日益增长的需求，并跟上锂基新能源领域的最新技术突破的步伐，进而推动公司的稳步发展。优质的上游锂资源提供强劲支持 拥有业内显著成本优势除了锂电方面，天齐锂业还是世界上少数几个同时拥有高质量硬岩锂矿和锂卤水矿的企业之一。通过泰利森的锂矿开采权，公司可使用格林布什矿场，按产量及储量计算，该矿场拥有世界最大的硬岩锂矿。泰利森于2021年的化学级锂精矿产量达102.0千吨LCE，使其成为全球最大的化学级锂精矿供货商。与此同时，天齐锂业通过对SQM持股，在战略上获得阿塔卡马盐湖的资源。阿塔卡玛盐湖于2021年为世界上最大的卤水制锂储地。按产量计算，SQM亦是2021年世界上最大的卤水锂化合物生产商。对SQM的战略持股增加了公司对SQM世界一流的卤水资源的布局，从而进一步巩固公司的行业地位，并产生稳定且具吸引力的长期财务回报。同时，凭借庞大优质的上游锂资源提供强劲支持，天齐锂业能够为锂化合物生产提供充足、稳定的原材料。在业务覆盖方面，得益于业务线之间的协同作用，天齐锂业的营运涵盖锂行业价值链的关键环节和方面，包括开采锂矿石及生产锂精矿、生产锂化合物及衍生物，能够有效应对不断变化的市场需求。天齐锂业是中国唯一通过大型、一致且稳定的锂精矿供给实现了100%自给自足并全面垂直整合的生产商。100%锂精矿自给自足，可实现具有一致性和高质量的各种终端产品的规模化生产及先进的生产技术，高度先进的生产技术为其提供成本优势，从而提高营运效率、安全性和盈利能力。客户群稳定、优质且庞大 盈利能力及核心竞争力增强作为全球锂行业的老牌领先企业，天齐锂业已建立稳定的优质客户群，主要包括全球顶级电池制造商、电池材料生产商、跨国电子公司和玻璃生产商。按2021年市场份额计，公司的产品供应给世界五大大型锂离子电池制造商中的三家制造商，以及世界十大正极材料制造商中的六家。天齐锂业凭借全面垂直整合的业务模式，能够取得显著的成本优势以及高盈利的能力。根据招股书，于2019年、2020年及2021年12月31日止年度，公司的收益分别为人民币4,816.4百万元、人民币3,215.2百万元及人民币7,597.9百万元。截至2021年12月31日止年度，公司录得净利润人民币4,205.8百万元。此外，在锂矿开采和生产方面，天齐锂业拥有长期且经证实的高效的营运往绩，凭借专业知识和过硬的技术实力，能够为电池行业供应链实现认证过程所要求的产品高度一致性和高质量，对市场准入构成了若干高壁垒。强大敬业的研发团队 发展空间有望进一步提升在研发方面，天齐锂业组建一个敬业的研发团队，其核心领导团队成员为来自对锂产品的研发至关重要的各类科学领域的经验丰富的专家。截至最后实际可行日期，公司合共166项专利获得授权，32项专利正处于申请阶段，包括若干行业领先的技术及产品创新。中长期来看，随着全球能源结构的调整以及满足「碳中和」的要求，储能系统将成为未来十年锂行业增长最快的终端市场之一。根据伍德麦肯兹报告，储能相关基础设施的锂消耗量预计自2022年至2026年以11.6%的复合年增长率增长，于2026年达59.0千吨LCE消耗量。成功的业务模式，显著的成本优势，领先的技术及庞大优质的客户群，均助力着天齐锂业长期受益行业高速发展带来的机遇。在港上市后，公司的行业地位有望进一步上升，市场份额不断扩大，具备更大的想象空间，值得期待。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
Tianda Pharmaceuticals Annual Results 2022
HONG KONG, Jun 30, 2022 - (ACN Newswire via SEAPRWire.com) - Tianda Pharmaceuticals Limited (Tianda Pharmaceuticals or the Group, stock code: 0455.HK) is pleased to announce its annual results for the year ended 31 March 2022. During the Reporting Period, the Group's business attained further development as revenue reached HK$510.0 million for the Current Financial Year, representing an increase of 7.5% compared to last year. Innovation and R&D made steady progress with R&D expenses increasing 34.7% year on year (YOY) to HK$15.9 million. With cash and cash equivalents of approximately HK$334.0 million as of 31 March 2022, the Group has sufficient financial resources to support its business development. To celebrate the 10th anniversary of the change of the Group's name to "Tianda Pharmaceuticals Limited", the Board of Directors recommended the payment of a final dividend of HK0.26 cent per share and a special dividend of HK0.56 cent per share to reward its shareholders for their support and trust over the years.The new R&D and production base located in Jinwan, ZhuhaiThe Pharmaceuticals and medical technologies business revenue reached HK$396.1 million, an increase of 10.7% YOY. The Group focuses on products and technology, actively introducing, developing and acquiring innovative drugs, generic drugs, healthcare products, and medical devices for cardiovascular and cerebrovascular, women and children, and respiratory system diseases, oncology and rehabilitation. The Group's major product, Tuoping Valsartan capsules, a medicine for cardio-cerebrovascular disease, became the No. 1 product in its category in China by sales quantity as it seized the opportunity of the success in securing first place in the nation's Third Round of Centralized Drug Procurement with Target Quantity to supply nationwide, which increased both sales and brand awareness. Through the integration of sales teams and channels, the Group's medicines, especially the pediatric drugs, Tuoen Ibuprofen oral suspension and Ibuprofen suspension drops, also achieved satisfactory sales growth. The Group's new R&D and production base in Jinwan, Zhuhai has commenced operations, with an investment of HK$430 million for the first phase of the development and is equipped with imported and domestic advanced automated equipment. The new base is poised to become a pharmaceutical and health industry base with high standard, quality and efficiency through innovation development, accelerated product lines enrichment and production capacity improvement. Five CDMO/CMO contracts have been successfully signed.The Chinese medicine business revenue reached HK$106.5 million, down 4.9% YOY. In the first nine months of the Reporting Period, the Chinese medicine business achieved faster growth by utilizing various methods to form mutually beneficial cooperation with partners such as medicinal materials farmers, cooperatives, distributors and pharmaceutical companies for building a nationwide and global business network for the Chinese medicinal materials business. Going forward, the Group will adopt a variety-centric approach to focus on domestic and overseas trading of Chinese medicinal materials, production and sales of TCM decoction pieces and formula granules, and distribution business, integrating quality resources from upstream to downstream for the industry.The Medical and healthcare services revenue reached HK$7.4 million, an increase of 57.4% YOY. The Group steadily advances the development of the modern Chinese medical clinic "TDMall" through self-construction, franchising and mergers and acquisitions. The priority is to expand in the Guangdong-Hong Kong-Macao Greater Bay Area while making plans for a national and global rollout. TDMalls have been opened in Zhuhai, Hong Kong and Sydney successively since 2019 with the aim to build the global chain operation model under three different local laws and regulations for Chinese medicine. Meanwhile, Zhuhai TDMall became the first Chinese medicine clinic in the world to receive both the ISO 9001:2015 Quality Management System Certification and Qualicert International Service Quality Certification. As part of its caring for people's health and CSR initiatives, the Group launched the "TDMall Cloud-based Global Anti-epidemic Chinese Medicine Platform" amid the fifth wave of the COVID-19 pandemic in Hong Kong in early 2022 to support the Group's "Free Consultation and Medicine" charity campaign to provide the public with comprehensive remote Chinese medicine services from prevention, treatment to rehabilitation, as well as Chinese medicine services for mitigating long COVID.China's "14th Five-Year Plan" proposes to comprehensively promote the construction of a healthy China, placing the protection of people's health as a strategic priority for development and providing people with comprehensive life-cycle health services. Adhering to the corporate slogan of "Tianda for Health!", the Group will continue to execute the strategy of "development of Chinese medicine business as a foundation, development of innovative drugs and medical technologies, as well as development of quality medical and healthcare services", implementing the "3D+1S" initiatives (business development (BD), research and development (R&D), investment and development (ID), and marketing & sales (S)) working in tandem to continuously enrich product lines and improve the quality and quantity of R&D projects in the pipeline through an external introduction, R&D, and mergers and acquisitions (M&A), as well as to identify cutting-edge technologies and products and quality projects worldwide in an effort to achieve high-quality development, so as to make a greater contribution to safeguarding the health of mankind.About Tianda Pharmaceuticals LimitedTianda Pharmaceuticals Limited is engaged in the development of the Chinese medicine business as a foundation, development of innovative drugs and medical technologies, as well as development of quality medical and healthcare services, committed to becoming a leading pharmaceutical enterprise that sets its footholds in China while expanding its presence worldwide.For enquiriesTianda Pharmaceuticals LimitedInvestor Relations Department Phone: +852 2545 3313 Email: ir@tianda.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
EC Healthcare and Yoho Group Form Strategic Partnership
HONG KONG, Jun 30, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited ("Yoho Group", SEHK stock code: 2347) for strategic collaboration. The partnership will be focused on accelerating the growth of medical, aesthetic medical and beauty and wellness services in the e-commerce market, and jointly boosting the e-commerce penetration of medical, aesthetic medical and beauty and wellness services in Hong Kong. The partnership will strengthen ECH's online presence in Hong Kong and expand its customer base and further consolidate the leading market position.Under the collaboration, (i) The Group will become Yoho Group's anchor merchant in beauty and healthcare services and Yoho Group will launch an online medical, aesthetic medical and beauty and wellness service zone. The dedicated section will enable the Group to reach a greater public domain traffic flow from the e-commerce platform with strong client synergy in the healthcare and beauty sector;(ii)Both Parties will strengthen their co-marketing efforts to increase the overall sales volume and promote product cross-sell; (iii) Both Parties agree to exchange know-how in precision marketing and consumer behavior analysis in healthcare and beauty sector, in order to develop more comprehensive digitalized marketing strategy to improve overall customer lifetime value; (iv) Both Parties will devote resources to jointly enhance technical solutions across social & mobile commerce, data-driven marketing, and fulfillment efficiency to streamline the entire consumer journey.Mr. Gemini Wong, Executive Director, Chief Digital Officer and Deputy Marketing Officer of EC Healthcare said, "The Group is delighted to establish a strategic partnership with Yoho Group. Through the collaboration, we hope to leverage Yoho Group's experience regarding online retail and the extensive reach to the accumulated customer traffic to boost the Group's e-commerce, diversify the digital marketing strategies and optimize the e-commerce experience so as to increase the overall sales volume, and raise the brand awareness and consolidate the leading position."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, focusing on preventive and precision medicine and leveraging investment in IT, brand, service and corporate culture to build a diversified enclosed healthcare ecosystem with the mission to bring health, beauty and happiness to everyone. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, a advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021About Yoho Group Holdings Limited Yoho Group Holdings Limited is one of the leading e-commerce platforms in Hong Kong, with more than 820,000 registered users as of the date of this announcement and over 2,290,000 monthly active users (based on the data in March 2022). According to Frost & Sullivan's data and the Group's revenue for the financial year ended 31 March 2021, the Group recorded the highest online retail sales among e-commerce players in consumer electronics and home appliances and acquired a market share of approximately 5.6%. Leveraging its vast customer base, the Group is expected to launch its online marketplace operations in the financial year ending 31 March 2023 to expand the product and service offerings for its customers. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
CortDAO Racing W Series Team Launches NFT Initiative To Supercharge Women’s Participation In Motorsports
Hopes to raise GBP1million with initial release; proceeds go to team sponsorship and CortDAO's W Series investment LONDON, June 30, 2022 - (ACN Newswire via SEAPRWire.com) - Women have been historically underrepresented in motorsport due to the lack of funding and opportunity. CortDAO, in partnership with W Series, is looking to change that dynamic. By appealing to the Web3 community and a growing women's motorsports fanbase, CortDAO is launching its first-ever series of NFTs, with its proceeds to be invested in W Series. CortDAO was founded by Michael Livingston with the mission to build a community-led platform that could authentically promote female racers and further women in motorsports. The first step of its mission was to launch a team in W Series, the world's first free-to-enter single-seater motor racing championship for women. Unveiled in March, the CortDAO Racing W Series Team now competes in the 2022 season of W Series and is preparing for the upcoming round at Silverstone, UK, alongside the F1 Lenovo British Grand Prix this weekend. CortDAO is looking at new ways to involve the Web3 community in its crowdfunding ventures, as well as engage with corporate sponsors who believe in its mission. With W Series Round 4 around the corner, the focus is now on releasing CortDAO's first-ever NFTs (non-fungible tokens) to secure additional investment. Launching on 30 June - a total of 10,000 NFTs depicting two bespoke CortDAO Racing assets (5,000 NFTs of each design with a unique identifier from 1 to 5,000) will be issued. The two designs, created by Team Quantum Punks, will be 3D virtual depictions of the limited-edition racing helmets of team drivers Marta Garcia (21, ESP) and Fabienne Wohlwend (24, LIE). One-third of the proceeds from the sale of CortDAO NFTs will go towards sponsorship of the team, and two-thirds of the proceeds will go towards CortDAO's investment in W Series Limited at the last traded price. CortDAO is looking to raise GBP1milion in this initial release, and in time, CortDAO will offer purchasers the opportunity to convert each NFT into a token. Michael Livingston (Founder CortDAO) "We have had many people wanting to assist in growing W Series and women's racing and have tried to price our NFTs as affordable as possible to our fanbase. Our NFTs will bring fans closer to the action and allow them to feel a sense of pride as their money will go towards supporting women struggling to succeed in a male-dominated sport. CortDAO will not receive any profits from the sale of its NFTs, so our intentions are genuine. The proceeds after costs will flow to W Series so that purchasers will be helping not only CortDAO and our brilliant drivers, Fabienne Wohlwend and Marta Garcia, but also the whole W Series." Follow: Instagram // Discord // TikTok // Twitter // OpenSea // Contact: Email: contact@cortdao.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
天大药业2022全年业绩
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 天大药业有限公司 (天大药业或本集团 ，股份代号 ：0455.HK) 欣然宣布截至2022年3月31日止全年业绩。报告期内，本集团整体业务取得较好发展，收入5亿1,000万港元，同比增长7.5% 。创新和研发工作稳步推进, 研发费用1,590万港元，同比增长34.7%。本集团财务状况稳健，于2022年3月31日现金和现金等价物为3亿3,400万港元，具充足财务资源支持业务发展。为庆祝本集团更名为「天大药业有限公司」10周年，董事会建议派发末期股息每股0.26港仙和特别股息每股0.56港仙，回馈股东长期的支持和信赖。位于珠海金湾的新研发及制药基地药物和医疗科技业务收入3亿9,610万港元，同比增长10.7%。药物和医疗科技业务重点关注产品和技术，积极引进、研发、倂购创新药、健康产品和医疗器械，聚焦心脑血管、妇儿、呼吸系统、肿瘤、康复等重点领域。本集团主要产品心脑血管用药托平®缬沙坦胶囊在中国市场同类产品中销量第一，凭借在国家第三批集中带量采购第一顺位中标，放量增长，扩大品牌影响力。通过销售团队和渠道的整合, 本集团药品尤其是儿科用药托恩®布洛芬混悬液和布洛芬混悬滴剂取得满意的销售增长。位于珠海金湾的新研发及制药基地已顺利投产，第一期投资金额4.3亿港元，配置进口和国产最新型自动化设备，立足创新发展，加快丰富产品线和提高产能，已成功签订5个CDMO/CMO合同，锐意成为一个高标准、高质量、高效能的医药健康产业基地。中医药业务收入1亿650万港元，同比减少4.9%。报告期首9个月，中医药业务实现较快增长，运用多种方式实现和药农、合作社、经销商、药企等伙伴的互惠合作，构建面向全国全球的中药材业务网络。未来，将以品种为中心，重点发展中药材国内外贸易，中药饮片、配方颗粒生产销售及配送业务，整合产业上下游优质资源。医疗和保健服务收入740万港元，同比增长57.4%。本集团稳健推进新型中医馆「天大馆」拓展，自建、加盟和并购并举，优先开拓粤港澳大湾区，兼顾全国全球布局。自2019年起先后在珠海、香港和悉尼三地不同的中医药管理法规下开馆，打造全球连锁运营模式, 其中珠海天大馆成为全球首家获ISO 9001:2015质量管理体系认证和Qualicert国际服务认证的中医馆。本集团关注民众健康及积极履行企业社会责任，在2022年初第五波新冠疫情袭击香港期间，本集团依托「云上天大馆」推出「天大馆全球中医云端科技抗疫平台」，开展「赠医施药 同心抗疫」公益大行动，为民众提供从预防、治疗到康复的全方位远程中医医疗服务，并推出新冠后遗症中医调理服务。国家「十四五」规划提出全面推进健康中国建设，把保障人民健康放在优先发展的战略位置，为人民提供全方位全生命期健康服务。本集团秉承「您的健康是天大的事！」这一使命，贯彻「以发展中医药产业为基础，发展创新药物和医疗科技，发展优质医疗和保健服务」战略，实施「3D+1S」重大举措 (业务拓展BD、研究开发R&D、投资发展ID、市场销售S)，联动并举，通过外部引进、研发、倂购等方式，不断丰富产品线和提高管线内研发项目的质量和数量，并在全球范围内洽寻前沿技术和产品以及优质项目，努力实现高质量发展，为守护人类健康做出更大贡献。有关天大药业有限公司天大药业有限公司(香港联交所上市公司，股份代号0455.HK)以发展中医药产业为基础，发展创新药物和医疗科技，发展优质医疗和保健服务，致力发展成为立足中国，辐射全球的领先医药企业。新闻查询天大药业有限公司投资者关系部电话：+852 2545 3313 电邮：ir@tianda.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
医思健康与友和集团建立战略合作伙伴关系
HONG KONG, Jun 30, 2022 - (亚太商讯 via SEAPRWire.com) - 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团与友和集团控股有限公司（「友和集团」；香港联交所股份编号：2347）就拟建立战略合作伙伴关系签署谅解备忘录。双方将合作重点推进香港医疗，美学医疗及美容养生于电子商务领域的快速发展，携手推动香港医疗，美学医疗及美容养生电子商务渗透率的提升。此次合作将强化集团的线上业务，扩大集团可触达的客群，进一步巩固集团的市场领先地位。就此次合作，(i)集团将成为友和集团在美容及医疗健康服务领域的主要商户，友和集团将为集团开设医疗，美学医疗及美容养生线上服务产品专区。这一专区将有望帮助集团引入更多电商平台上的公域客户流量，并创造医疗及医美客户群与友和集团的协同效益；(ii)集团将与友和集团联手推动相关服务产品的线上营销活动以提升销售额，丰富产品组合及提升交叉销售；(iii)集团将与友和集团就精准营销及消费者行为分析方面的洞见进行合作，以发展更全面的数字营销策略，提高客户的生命周期价值；(iv)集团将携手友和集团共同发展电子商务科技，双方将投入资源提升社交电商及电子商务解决方案的技术水平，数据驱动的营销能力，满足客户需求的运营效率，以优化消费者体验。医思健康执行董事兼首席数码执行官及副市场营销官黄志昌先生总结：「集团很高兴能与友和集团达成战略合作。通过是次合作，集团希望相信通过借助友和集团在线上零售领域的经验和累积的丰富客户流量，帮助集团强化电商业务布局，以及深化数码营销策略，为客户带来更便捷的电子商务体验，以进一步推动销售增长，品牌知名度的提升，从而巩固集团的行业领先地位。」关于医思健康香港最大非医院医疗服务供应商*医思健康以预防及精准医疗为业务核心，通过资讯科技，服务，品牌和文化的不断投入，搭建一个完善的多元大健康闭环生态，致力于让这个世界变得更健康、美丽、快乐。集团为恒生综合指数成份股及MSCI香港小型股指数。 集团目前直营的诊所／服务中心主要位于大湾区，提供一站式医疗及健康服务。服务涵盖面极广，旗下主要知名服务品牌包括连续多年荣膺全港第一的一站式医学美容解决方案DR REBORN、专业健发中心发森及多元化多维度的医学服务包括：健康管理中心香港仁和体检中心、疫苗中心香港安苗医疗中心、普通科门诊未来医生、全港最大一站式痛症管理平台纽约脊骨物理治疗中心、全方位牙科服务中心庇利积臣牙科医务所，EC DENTAL CARE及恒健牙科医务所、高端影像中心博思医学诊断中心、仁生肿瘤及癌症中心、内视镜及日间医疗中心仁辉专科中心、专科中心进汇医务中心，联汇专科，新医疗中心、儿科专科汇儿儿科医务中心、妇产科专科卓越医务中心及产前诊断中心、柏立医学化验所、眼科中心唯视眼科和医思兽医医院及影像中心。*根据弗若斯特沙利文公司按2020年及2021年收入计算进行的独立研究关于友和集团控股有限公司友和集团控股有限公司为香港电子商务平台翘楚之一，于本公告日期的注册会员超过820,000人及每月活跃用户超过2,290,000名（按2022年3月数据计算）。根据弗若斯特沙利文的数据及本集团截至2021年3月31日止财政年度的收益，本集团在电子商务平台参与者中录得最高电子产品及家庭电器线上零售，市场占有率约为5.6%。凭借庞大的客户群，预期本集团于截至2023年3月31日止财政年度推出其线上平台业务，扩大为客户提供的产品及服务种类。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022
Awards recognize Avantor innovations that allow the biopharmaceutical industry to bring therapies to market more efficientlyIncheon, Korea, June 30, 2022 - (ACN Newswire via SEAPRWire.com) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, acquired awards for the best company in upstream processing and single-use solutions at the Biologics Manufacturing Korea (BMK) 2022 conference.Sang Kyu Lee, Representative Director - Avantor Korea/Japan (Left), James Hwang, Head of Application, Asia, Middle East & Africa – Biopharma after receiving the Awards for Best Company in Single-use Solutions and Upstream Processing at BMK 2022This is the second consecutive year that Avantor has been recognized for its upstream processing capabilities, a testament to its ongoing investment and innovations including development of high-purity raw materials, reagents and differentiated cell culture processes. In single-use solutions, Avantor received the best company award for the third consecutive year. Avantor was recognized for strengthening production capabilities and establishing an optimized supply chain in collaboration with global partners to respond to the growing need of biopharmaceutical manufacturers for single-use solutions.Narayana Rao Rapolu, Vice President, Biopharma Asia Middle East & Africa for Avantor said, “Avantor's single-use solutions enable biomanufacturers to bring new therapies to market faster and improve global health. Our local teams have expertise and experience across multiple processes that drive therapies forward from prototype development to system design, production and delivery. We offer the choice, agility and speed needed to support the evolving life-sciences market in Korea and across the region.”Sang Kyu Lee, Representative Director for Avantor Korea & Japan said, “We are proud to be recognized for Avantor's ability to support biopharmaceutical manufacturers through our comprehensive product portfolio and customer-driven production technologies. We continue to introduce innovations that allow life-changing therapies to reach the patients who need them.”About AvantorAvantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.About The Korea Bioprocessing Excellence AwardsThe Korea Bioprocessing Excellence Awards aims to recognize organizations within Korea that have engaged in substantial efforts to innovate, optimize processes and uphold a high level of efficacy, quality and safety in biological products manufacturing.Regional Media Contact:Christina KohDirector, Communications - AMEAAvantorM: +65 9720 0169Christina.Koh@avantorsciences.comGlobal Media Contact:Petro KacurDirector, PR and External CommunicationsAvantorM: 404-408-0663Petro.Kacur@avantorsciences.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
Indonesian calls, messages at G7 Summit
JAKARTA, Jun 30, 2022 - (ACN Newswire via SEAPRWire.com) - Indonesian President Joko Widodo (Jokowi) has arrived at the venue of the 48th G7 Summit in Schloss Elmau, Germany on Monday afternoon (June 27) local time (UTC+1) to attend the meeting in the capacity of a partner country and as the G20 President.Indonesian President Joko Widodo in conversation with French President Emmanuel Macron and United States President Joe Biden while attending the G7 Summit in Elmau, Germany, Monday, June 27, 2022. ANTARA/HO-Press Bureau of the Presidential Secretariat/Laily Rachev/aa/ak. (Handout of Press Bureau of the Presidential Secretariat/Laily R)The G7 is an informal forum bringing together leaders of the world's leading industrial nations from the European Union and countries such as Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States.Jokowi was welcomed by German Chancellor Olaf Scholz.During the official welcoming session by the chancellor, Jokowi was present with the leaders of G7 partner countries, including Argentine President Alberto Fernandez, Indian Prime Minister Narendra Modi, Senegalese President Macky Sall, and South African President Cyril Ramaphosa.Furthermore, during the photo session, he posed for a picture accompanied by the German chancellor and United States President Joe Biden.All heads of government attended two sessions of the G7 meeting.President Jokowi invited G7 countries to contribute to capitalizing on investment opportunities in the clean energy sector in Indonesia.President Jokowi conveyed the statement while attending the G7 Summit working lunch session based on the topics of climate change, energy, and health in Elmau, Germany, Monday (June 27)."(This is) especially (regarding) investment opportunities in the clean energy sector in Indonesia, including the development of an electric car and lithium battery ecosystem," the president stated.According to President Jokowi, Indonesia's potential, as a contributor to clean energy, whether in the bowels of the earth, on land, or at sea, is very large. Indonesia needs large investments and low-carbon technologies to support a fast and effective transition to clean energy."Indonesia needs at least US$25-30 billion for energy transition in the next eight years. We can optimize this transition as a motor of economic growth, open up business opportunities, and create new jobs," President Jokowi stated.Furthermore, the president noted that in Indonesia as well as in other developing countries, the risk of climate change is very real, especially since it is an archipelagic country, with 17 thousand islands. The risks are not only detrimental to health but also put farmers and fishermen in trouble."We really hope for the support of all G7 countries in the Indonesian Presidency at the G20. See you in Bali. Thank you," the president stated.During session II of the G7 summit on the topics of food security and gender equality, President Jokowi called on G7 and G20 countries to jointly overcome the food crisis that currently threatens people in developing countries to fall into extreme hunger and poverty."(Some) 323 million people in 2022, according to the World Food Programme, are at risk of facing acute food insecurity. The G7 and G20 have a big responsibility to overcome this food crisis. Let us fulfill our responsibilities now and from now on," President Jokowi affirmed.According to the president, food is the most basic human rights issue. Indubitably, women from poor families suffer the most from food shortages for their children and families."We must act quickly to find a concrete solution. Food production must be increased. The global food and fertilizer supply chain must return to normal," the president stated.In his speech, President Jokowi emphasized the importance of G7 countries' support for the reintegration of Ukraine's wheat exports and Russia's exports of food and fertilizer commodities in global supply chains.There are two ways to realize this, with the first being the facilitation of Ukraine's grain exports that can begin immediately.According to the president, the second approach is proactive communication with the public worldwide that food and fertilizer commodities from Russia are not subject to sanctions."This intensive communication is very necessary, so that there is no prolonged doubt in the (minds of the) international public. This intensive communication also needs to be strengthened with communication with related parties, such as banks, insurance, shipping, and others," the president explained.President Jokowi had paid significant attention to the impact of the war on food and fertilizer supply chains."(This is) especially for fertilizers, because if we fail to handle it, then a rice crisis involving two billion people, especially in developing countries, can occur," the president cautioned.At the end of his remarks, the president again called for the importance of the G7 and G20 countries to jointly overcome this food crisis while also inviting G7 leaders to attend the G20 Summit in Bali."I am waiting for the G7 leaders to attend the G20 summit. See you in Bali, on November 15-16, 2022," President Jokowi stated.Meanwhile, Minister of Foreign Affairs Retno Marsudi noted that the president held about nine bilateral meetings with: the Prime Minister of India; French President; Prime Minister of Canada; Chancellor of Germany; British Prime Minister; Prime Minister of Japan; President of the European Commission; President of the Council of Europe; and the Managing Director of the IMF.During the bilateral meetings, besides inviting other countries to solve the problems of the food supply chain, president Jokowi also highlighted the preparations for the G20 Summit."In these meetings, we can clearly see that support for the Indonesian Presidency is still very strong," Marsudi noted.In 2022, Germany takes over the G7 Presidency and hosts the 48th G7 summit held on June 26-28, 2022, in Schloss Elmau.The G7, originally G8, was set up in 1975.The annual G7 summits have, over the years, developed into a platform for determining the course of multilateral discourse and shaping political responses to global challenges.Written by: Azis Kurmala, Editor: Fardah Assegaf (c) ANTARA 2022 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
Leon Fuat Berhad Shareholders Vote to Pass All Resolutions at AGM
Shareholders also approved a final single-tier dividend of 2.0 sen per share for FY2021 SHAH ALAM, Malaysia, June 28, 2022 – (ACN Newswire) – Leon Fuat Berhad, a manufacturer and trader of steel products, specialising in rolled long and flat steel products, is pleased to announce that shareholders have passed all resolutions at the Group’s 15th AGM held today. Mr. Calvin Ooi Shang How, Executive Director of Leon Fuat Shareholders passed a resolution approving a final single tier dividend of 2.0 sen per share for the financial year ended 31 December 2021 (FY2021). Shareholders also voted to re-elect Dato’ Sri Ooi Bin Keong, Mr. Tan Did Heng, Mr. Tan Sack Sen and Dato Lim Cheng Poh as directors as well as to retain Mr. Chan Kee Loin as an independent director. Also retained as independent directors were Did Heng and Sack Sen. Among the other resolutions up for voting, shareholders reappointed Baker Tilly Monteiro Heng PLT as the Group’s auditors and authorised the directors to fix the remuneration of the auditors. Mr. Calvin Ooi Shang How, Executive Director of Leon Fuat said, “We are happy to meet our shareholders again in a physical setting for the 15th AGM after having held the previous AGM virtually. We would like to thank shareholders for their trust and confidence in us as we navigated a challenging FY2021. Our financial performance for the first quarter ended 31 March 2022 was satisfactory despite the decrease in overall gross profit margin.” “We are cautiously optimistic of achieving profitable results for the remaining quarters of FY2022 but would like to point out that the outlook has dimmed considerably with the World Bank having cut global economic growth outlook to 2.9% for this year from the 4.1% growth outlook it had forecast in January 2022. To mitigate risks, the Group will continue to monitor steel prices closely as well as related foreign currencies. We will also take proactive measures such as anticipating price and currency volatility through negotiating forward contracts as well as prudent inventory management.” Leon Fuat Berhad: [BURSA: LEFU] , https://www.leonfuat.com.my/
国轩高科拟在欧洲投建年产18GWh生产基地
EQS 新闻 / 2022-06-29 / 09:22 UTC+8 国轩高科拟在欧洲投建年产18GWh生产基地 - 国轩高科的哥廷根基地预计分两期完成6GWh和12GWh，国轩电池开启“欧洲造”步伐 - 首款海外便携储能品牌GenDome亮相哥廷根基地，首款产品拟在哥廷根实现本地化生产 6月27日，国轩高科在德国哥廷根工厂举行了第五届新能源经济论坛暨德国国轩开幕仪式。据悉，哥廷根基地作为国轩在欧洲的首个电池生产运营基地，预计今年底启动改造。董事长李缜表示，国轩将中国先进的电池技术与德国先进的工艺工程完美地结合，正式开启国轩电池“欧洲造”步伐。当天的仪式上，国轩高科还发布了其首款面向海外市场的便携储能产品品牌GenDome及首款便携移动储能产品Gendock 3000。 中国驻德国特命全权大使吴恳，德国下萨克森州州长斯蒂芬‧魏尔，安徽省委常委、常务副省长刘惠、哥廷根市市长佩特拉‧布鲁伊斯特、合肥市人民政府市长罗云峰等中德政要与国轩高科董事长李缜共同参与并见证。 哥廷根基地首期6GWh预计今年底启动改造 据悉，哥廷根基地基地占地面积约17.4万平方米，现有建筑面积约4万平方米。根据规划，该项目分棕地工厂和绿地工厂两期建设，年产目标分别为6GWh和12GWh，其中第一期棕地工厂改造建设预计2022年底正式启动，2023年9月实现第一条产线3.5GWh的正式投产。基地棕地和绿地工厂完全投产后预计可实现年产18GWh的产能目标。 国轩哥廷根工厂厂长 Ahmet Toptas博士介绍：哥廷根基地会以产品为导向，以实现碳中和为终极目标，打造欧洲本土化的产品研发团队，结合欧洲新能源市场发展与技术导向，研发符合欧洲本土的新能源电池产品，开展大巴电池、汽车电池、储能电池、移动充电等系列产品的生产，未来客户拟覆盖储能、商用车及乘用车领域。“国轩高科先进的磷酸铁锂电芯技术，加上经验丰富的德国员工，严格的质量管控和欧洲高标准的品质要求，未来客户拟覆盖储能、商用车及乘用车领域，满足欧洲新能源市场的需求，助力国轩高科加速开拓海外市场。” 首款海外便携储能产品将在哥廷根本地化制造 继国轩高科5月份发布了半固态电池和首款智能移动储能充电桩之后，国轩高科的电池产品家族再添新成员。开幕仪式当天，哥廷根基地发布了首个面向海外市场的便携储能产品品牌GenDome，及其首款大容量便携移动储能产品Gendock 3000，可将太阳能和风能转化为电能；可帮助客户管理家庭能源使用，满足日常家庭和户外使用需求，能够满足客户99%的电力需求，有效减少能源支付账单。该款家用储能产品有三种不同型号，由国轩高科的国际业务团队研发及制造，未来主要面向欧洲市场，后期该产品将在哥廷根基地实现本地化制造。 开幕仪式当天，由国轩高科、百人会(Committee of 100)、布伦瑞克大学(Technical University of Braunschweig)、哥廷根经济促进与城市发展协会(GWG)和德国中国商会(Die Chinesische Handelskammer in Deutschland, CHKD)、同济大学汽车学院等联合举办的第五届新能源经济论坛也在哥廷根工厂顺利召开。论坛围绕中欧经济关系、能源革命、低碳化、新能源市场等话题进行讨论，吸引了新能源产业多家名企高管，大学教授学者及相关经济政要参加。 国轩高科董事长李缜: 中国技术加德国工艺，国轩电池开启“欧洲造” 国轩高科国际业务总裁李晨在闭幕致辞中介绍，国轩高科是一家全球化公司，为海内外供应商、客户等其他合作伙伴提供能源解决方案。“我们不仅聚焦新能源电池产品开发和推广，同步也致力于开拓TC业务。”李晨表示，2022年5月至今，国轩陆续发布国轩自主研发的首款面向普通消费者的易佳电智能移动储能充电桩产品和面向海外市场的Gendome便携储能产品。2025年国轩高科全球产能规划将达到300GWh，其中海外产能规划100GWh。 国轩高科董事长李缜在致辞中表示，今天我们在这里开启国轩电池在德国乃至欧洲的应用研发和产品制造。国轩的哥廷根工厂，将逐步从过去的生产汽车零部件，转变成制造电池应用产品，这是一个艰难但充满希望的历程。在此过程中一要保护好已有的企业文化，二要积极参与哥廷根的城市发展，三要加快产品转型的步伐。“我们一定将中国先进的电池技术，德国先进的工艺工程，完美地结合起来，创造更加美善的产品，贡献给社会，以推动新能源产业的进步与发展。” 文件: 国轩高科拟在欧洲投建年产18GWh生产基地 2022-06-29 此财经新闻稿由EQS Group转载。本公告内容由发行人全权负责。 原文链接: http://www.todayir.com/sc/index.php
博固泰®（特立帕肽注射液）上市申请 已经正式获中国国家药品监督管理局(NMPA)受理
EQS 新闻 / 2022-06-29 / 09:00 UTC+8 博固泰®（特立帕肽注射液）上市申请 已经正式获中国国家药品监督管理局(NMPA)受理 [2022年6月28日 – 香港]具备研发、生产及销售的一体化生物制药商——联康生物科技集团有限公司（「联康集团」或「本公司」，连同其附属公司统称「本集团」，股票代号：00690.HK）欣然宣布，本集团自主研发的博固泰®（特立帕肽注射液）递交的上市申请已于2022年6月28日获得中国国家药品监督管理局（「NMPA」）受理，受理号为“CXSS2200062国”。若本公司研发的博固泰®获得上市许可，将为患者提供更优的用药选择，是公司在骨科疾病领域的一项重大里程碑。 博固泰®（特立帕肽注射液）是集团继金因肽®、金因舒®、匹纳普®、博舒泰®之后上市的第五款产品，也是国内首款在一次性注射笔中推出PTH水针的国产品种。该产品是本公司与瑞士自我护理巨头Ypsomed合作开发的，拥有极细的注射针头和极高的剂量准确性，可极大减轻患者的注射痛苦。本集团坚信，博固泰®将能凭借其更强的成本优势，更好的治疗效果及便捷的给药方式，成为集团未来的重磅产品之一。 特立帕肽注射液采用生物表达技术，是一种重组人甲状旁腺激素类似物（PTH1-34），与84个氨基酸的人甲状旁腺激素的34位N末端氨基酸（生物活性区）具有相同的序列，用于治疗有骨折高发风险的绝经后妇女骨质疏松症，是国内外唯一批准上市的促骨形成类抗骨松药物，能够有效改善骨微结构、增加骨强度，同时能促进骨愈合，可显著降低绝经后妇女椎骨和非椎骨骨折风险。 我国是全世界骨质疏松人数最多的国家，根据2021年第七次人口普查的数据显示，目前我国60岁及以上人口为26402万，占比18.70%。流行病学调查显示:我国50岁以上人群骨质疏松症患病率女性为20.7%，男性为14.4%；60岁以上人群骨质疏松症患病率明显增高，并且女性尤为突出，高达51.6%。目前我国骨质疏松患者约为9000万人，骨质疏松市场规模约150-200亿元，目前特立帕肽占比仅为1%左右，较国外存在显著差距，主要在于价格昂贵且没有进入医保。但长期来看，随着我国人口老龄化加剧，医保体系覆盖的逐步健全和居民支付能力的提升，特立帕肽市场规模将明显加速增长。此外，博固泰®将凭借更高的成本效益、更安全有效的产品定位，契合目标患者人群的需求，较其他同类竞争对手比，也将确保更快的增长。 -完- 关于联康生物科技集团 联康生物科技集团有限公司主要从事药品研发、制造及分销之业务。集团研发中心备有整套系统，用于研发基因工程药品，并设有一个合乎国家药品监督管理局要求的中试车间和质量管控系统。集团亦分别于北京及深圳各设有一个符合最新药品生产质量管理规范（cGMP）的生产基地。同时，集团还拥有高效的商业化平台和营销网络。集团专注为糖尿病、骨质疏松等内分泌科、眼科及皮肤科研发创新的治疗药物。想了解更多详情，请访问联康集团官网：www.uni-bioscience.com。 如有相关咨询，请联络： 电子邮箱：ir@uni-bioscience.com 文件: 博固泰®（特立帕肽注射液）上市申请 已经正式获中国国家药品监督管理局(NMPA)受理 2022-06-29 此新闻稿由EQS Group转载。本公告内容由发行人全权负责。 原文链接: http://www.todayir.com/sc/index.php